… relating to their vaccination state and previous SARS-COV-2 infection. In the samples
collected we only measured the anti-SARS-COV-2 antibodies, eliminating the remaining sample. …

… of antibodies directed against the SARS-CoV-2 … antibody responses to SARS-CoV-2 infection
or vaccination. The qualitative and quantitative analysis of antibodies against SARS-CoV-2 …

… -2 belongs to the same large family of viruses as those that caused the MERS and SARS
outbreak, we could assume that its antibody generation process is similar. During the outbreak …

… OC43 N correlated with lower IgG to SARS-CoV-2 N in rRT-PCR … Antibodies to SARS-CoV-2
N were higher in patients with … of SARS-CoV-2-specific and HCoV crossreactive antibodies, …

… as SARS-CoV-2 has exercised to its limits nearly all aspects of modern viral diagnostics. In
doing so, it has illuminated both the advantages and limitations … and detection antibodies. The …

… , IgA, IgG and/or IgM) with follow-up duration of greater than 28 days (which we defined as
the limit of the acute phase of illness). Shorter follow-up studies were included if they reported …

… We have low confidence in these findings given the limitations of the evidence base, including
small study sizes, inconsistent adjustment for confounding factors, and lack of precision in …

… with authentic SARS-CoV-2 and a recombinant vesicular stomatitis virus carrying SARS-CoV-2 …
neutralizing antibodies that target two distinct domains of the SARS-CoV-2 spike protein. …

… Antibody cocktails that include S309 in combination with other antibodies that we identified
further enhanced SARS-CoV-2 neutralization, and may limit the emergence of neutralization-…

… (<0.40 U/ml), the manufacturer’s claimed limit of quantitation of 0.40 U/ml was verified, and
… , antibody response showed high interindividual variation in level and time of peak antibody …